je.st

Home › cancer

Tag: cancer

Light-Based Technologies At Work: Seeing' Through Walls, Monitoring Cancer Treatments And Air Pollution, Preserving Artworks -- And Much More

2015-07-08 05:57:05| pollutiononline News Articles

Co-located major European conferences in optical metrology and biomedical optics held in Munich, Germany, 21-25 June, featured highlights including two Nobel Laureates who presented during an International Year of Light (IYL2015) session on their pioneering work to enhance the resolution of microscopes

Tags: more work much air

Cancer Genetics Inc. Announces a Partnership With ICON's Laboratory...

2015-07-07 21:33:36| Biotech - Topix.net

Cancer Genetics, Inc. , an emerging leader in DNA-based diagnostics, announced today that it has entered into a partnership with the Laboratory Services group of ICON plc, the global CRO . ICON's Laboratory Services provide global testing services to the pharmaceutical, biotechnology and medical device industries.

Tags: partnership cancer laboratory icons

How Breast Density Can Affect Cancer Screenings

2015-07-06 22:39:59| Electronics - Topix.net

When it comes to breast cancer screening, the density of your breasts affects how well a mammogram can detect cancerous tissues. That's why Pennsylvania and 20 other states have adopted laws requiring radiologists to include information about breast density in every woman's mammogram report.

Tags: affect cancer density breast

MM-398 Receiving The Priority Review Designation By US FDA For New Drug Application And The Acceptance Of Market Authorization Application By EMA In Post-Gemcitabine Metastatic Pancreatic Cancer

2015-07-01 08:52:42| drugdiscoveryonline Home Page

PharmaEngine, Inc. (TWO: 4162) announced that (1) its license partner, Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK), has received the notification from the US Food and Drug Administration (FDA) for the acceptance and the grant of the priority review designation for their New Drug Application (NDA); and (2) its sublicense partner, Baxalta Incorporated, a wholly owned subsidiary of Baxter International Inc. (NYSE: BAX) has received the acceptance of Market Authorization Application (MAA) from the European Medicines Agency (EMA), of MM-398 (irinotecan liposome injection, also known as "nal-IRI,") in the treatment of patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy

Tags: review market application drug